A risk-benefit assessment of serotonin 5-HT3 receptor antagonists in antineoplastic therapy-induced emesis. [electronic resource]

By: Producer: 19980311Description: 43-56 p. digitalISSN:
  • 0114-5916
Subject(s): Online resources: In: Drug safety vol. 18
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
No physical items for this record

Publication Type: Journal Article; Review

There are no comments on this title.

to post a comment.